Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey

Amy Nunn, Nickolas Zaller, Samuel Dickman, Catherine Trimbur, Ank Nijhawan, Josiah D. Rich

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Background: More than 50% of incarcerated individuals have a history of substance use, and over 200,000 individuals with heroin addiction pass through American correctional facilities annually. Opiate replacement therapy (ORT) with methadone or buprenorphine is an effective treatment for opiate dependence and can reduce drug-related disease and recidivism for inmates. Provision of ORT is nevertheless a frequently neglected intervention in the correctional setting. Objective and methods: We surveyed the 50 state; Washington, District of Columbia (DC); and Federal Department of Corrections' medical directors or their equivalents about their facilities' ORT prescribing policies and referral programs for inmates leaving prison. Results: We received responses from 51 of 52 prison systems nationwide. Twenty-eight prison systems (55%) offer methadone to inmates in some situations. Methadone use varies widely across states: over 50% of correctional facilities that offer methadone do so exclusively for pregnant women or for chronic pain management. Seven states' prison systems (14%) offer buprenorphine to some inmates. The most common reason cited for not offering ORT was that facilities "prefer drug-free detoxification over providing methadone or buprenorphine." Twenty-three states' prison systems (45%) provide referrals for some inmates to methadone maintenance programs after release, which increased from 8% in 2003; 15 states' prison systems (29%) provide some referrals to community buprenorphine providers. Conclusion: Despite demonstrated social, medical, and economic benefits of providing ORT to inmates during incarceration and linkage to ORT upon release, many prison systems nationwide still do not offer pharmacological treatment for opiate addiction or referrals for ORT upon release.

Original languageEnglish (US)
Pages (from-to)83-88
Number of pages6
JournalDrug and Alcohol Dependence
Volume105
Issue number1-2
DOIs
StatePublished - Nov 1 2009

Fingerprint

Opiate Alkaloids
Opiate Substitution Treatment
Prisons
Buprenorphine
Methadone
Referral and Consultation
Opioid-Related Disorders
Heroin Dependence
Physician Executives
Medical Economics
Pain Management
Surveys and Questionnaires
Detoxification
Chronic Pain
Pharmaceutical Preparations
Heroin
Pregnant Women
Pharmacology

Keywords

  • Buprenorphine
  • Corrections
  • Methadone
  • Opiate replacement therapy
  • Prison

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Methadone and buprenorphine prescribing and referral practices in US prison systems : Results from a Nationwide Survey. / Nunn, Amy; Zaller, Nickolas; Dickman, Samuel; Trimbur, Catherine; Nijhawan, Ank; Rich, Josiah D.

In: Drug and Alcohol Dependence, Vol. 105, No. 1-2, 01.11.2009, p. 83-88.

Research output: Contribution to journalArticle

Nunn, Amy ; Zaller, Nickolas ; Dickman, Samuel ; Trimbur, Catherine ; Nijhawan, Ank ; Rich, Josiah D. / Methadone and buprenorphine prescribing and referral practices in US prison systems : Results from a Nationwide Survey. In: Drug and Alcohol Dependence. 2009 ; Vol. 105, No. 1-2. pp. 83-88.
@article{6d64454e506c4ea3b62ee1fe0230abd9,
title = "Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey",
abstract = "Background: More than 50{\%} of incarcerated individuals have a history of substance use, and over 200,000 individuals with heroin addiction pass through American correctional facilities annually. Opiate replacement therapy (ORT) with methadone or buprenorphine is an effective treatment for opiate dependence and can reduce drug-related disease and recidivism for inmates. Provision of ORT is nevertheless a frequently neglected intervention in the correctional setting. Objective and methods: We surveyed the 50 state; Washington, District of Columbia (DC); and Federal Department of Corrections' medical directors or their equivalents about their facilities' ORT prescribing policies and referral programs for inmates leaving prison. Results: We received responses from 51 of 52 prison systems nationwide. Twenty-eight prison systems (55{\%}) offer methadone to inmates in some situations. Methadone use varies widely across states: over 50{\%} of correctional facilities that offer methadone do so exclusively for pregnant women or for chronic pain management. Seven states' prison systems (14{\%}) offer buprenorphine to some inmates. The most common reason cited for not offering ORT was that facilities {"}prefer drug-free detoxification over providing methadone or buprenorphine.{"} Twenty-three states' prison systems (45{\%}) provide referrals for some inmates to methadone maintenance programs after release, which increased from 8{\%} in 2003; 15 states' prison systems (29{\%}) provide some referrals to community buprenorphine providers. Conclusion: Despite demonstrated social, medical, and economic benefits of providing ORT to inmates during incarceration and linkage to ORT upon release, many prison systems nationwide still do not offer pharmacological treatment for opiate addiction or referrals for ORT upon release.",
keywords = "Buprenorphine, Corrections, Methadone, Opiate replacement therapy, Prison",
author = "Amy Nunn and Nickolas Zaller and Samuel Dickman and Catherine Trimbur and Ank Nijhawan and Rich, {Josiah D.}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.drugalcdep.2009.06.015",
language = "English (US)",
volume = "105",
pages = "83--88",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Methadone and buprenorphine prescribing and referral practices in US prison systems

T2 - Results from a Nationwide Survey

AU - Nunn, Amy

AU - Zaller, Nickolas

AU - Dickman, Samuel

AU - Trimbur, Catherine

AU - Nijhawan, Ank

AU - Rich, Josiah D.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Background: More than 50% of incarcerated individuals have a history of substance use, and over 200,000 individuals with heroin addiction pass through American correctional facilities annually. Opiate replacement therapy (ORT) with methadone or buprenorphine is an effective treatment for opiate dependence and can reduce drug-related disease and recidivism for inmates. Provision of ORT is nevertheless a frequently neglected intervention in the correctional setting. Objective and methods: We surveyed the 50 state; Washington, District of Columbia (DC); and Federal Department of Corrections' medical directors or their equivalents about their facilities' ORT prescribing policies and referral programs for inmates leaving prison. Results: We received responses from 51 of 52 prison systems nationwide. Twenty-eight prison systems (55%) offer methadone to inmates in some situations. Methadone use varies widely across states: over 50% of correctional facilities that offer methadone do so exclusively for pregnant women or for chronic pain management. Seven states' prison systems (14%) offer buprenorphine to some inmates. The most common reason cited for not offering ORT was that facilities "prefer drug-free detoxification over providing methadone or buprenorphine." Twenty-three states' prison systems (45%) provide referrals for some inmates to methadone maintenance programs after release, which increased from 8% in 2003; 15 states' prison systems (29%) provide some referrals to community buprenorphine providers. Conclusion: Despite demonstrated social, medical, and economic benefits of providing ORT to inmates during incarceration and linkage to ORT upon release, many prison systems nationwide still do not offer pharmacological treatment for opiate addiction or referrals for ORT upon release.

AB - Background: More than 50% of incarcerated individuals have a history of substance use, and over 200,000 individuals with heroin addiction pass through American correctional facilities annually. Opiate replacement therapy (ORT) with methadone or buprenorphine is an effective treatment for opiate dependence and can reduce drug-related disease and recidivism for inmates. Provision of ORT is nevertheless a frequently neglected intervention in the correctional setting. Objective and methods: We surveyed the 50 state; Washington, District of Columbia (DC); and Federal Department of Corrections' medical directors or their equivalents about their facilities' ORT prescribing policies and referral programs for inmates leaving prison. Results: We received responses from 51 of 52 prison systems nationwide. Twenty-eight prison systems (55%) offer methadone to inmates in some situations. Methadone use varies widely across states: over 50% of correctional facilities that offer methadone do so exclusively for pregnant women or for chronic pain management. Seven states' prison systems (14%) offer buprenorphine to some inmates. The most common reason cited for not offering ORT was that facilities "prefer drug-free detoxification over providing methadone or buprenorphine." Twenty-three states' prison systems (45%) provide referrals for some inmates to methadone maintenance programs after release, which increased from 8% in 2003; 15 states' prison systems (29%) provide some referrals to community buprenorphine providers. Conclusion: Despite demonstrated social, medical, and economic benefits of providing ORT to inmates during incarceration and linkage to ORT upon release, many prison systems nationwide still do not offer pharmacological treatment for opiate addiction or referrals for ORT upon release.

KW - Buprenorphine

KW - Corrections

KW - Methadone

KW - Opiate replacement therapy

KW - Prison

UR - http://www.scopus.com/inward/record.url?scp=69949089584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949089584&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2009.06.015

DO - 10.1016/j.drugalcdep.2009.06.015

M3 - Article

C2 - 19625142

AN - SCOPUS:69949089584

VL - 105

SP - 83

EP - 88

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-2

ER -